| Splenomegaly–Diagnostic validity, work-up, and underlying causes E Curovic Rotbain, D Lund Hansen, O Schaffalitzky de Muckadell, ... PloS one 12 (11), e0186674, 2017 | 47 | 2017 |
| Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib K Aarup, EC Rotbain, L Enggaard, RS Pedersen, OJ Bergmann, ... European journal of haematology 105 (5), 646-654, 2020 | 42 | 2020 |
| Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death EC Rotbain, CU Niemann, K Rostgaard, C da Cunha-Bang, H Hjalgrim, ... Leukemia 35 (9), 2570-2580, 2021 | 32 | 2021 |
| IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study EC Rotbain, H Frederiksen, H Hjalgrim, K Rostgaard, GJ Egholm, ... haematologica 105 (6), 1621, 2020 | 29 | 2020 |
| Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population‐based study C da Cunha‐Bang, K Rostgaard, MA Andersen, EC Rotbain, K Grønbæk, ... British journal of haematology 193 (2), 339-345, 2021 | 20 | 2021 |
| Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies C Gren, MR Spiegelhauer, EC Rotbain, BK Ehmsen, P Kampmann, ... Access Microbiology 1 (8), e000048, 2019 | 20 | 2019 |
| The CLL comorbidity index in a population-based cohort: a tool for clinical care and research EC Rotbain, MJ Gordon, N Vainer, H Frederiksen, H Hjalgrim, AV Danilov, ... Blood advances 6 (8), 2701-2706, 2022 | 16 | 2022 |
| Development and validation of a Nordic multimorbidity index based on hospital diagnoses and filled prescriptions KB Kristensen, LC Lund, PB Jensen, A Broe, E Rotbain, P Damkier, ... Clinical Epidemiology, 567-579, 2022 | 14 | 2022 |
| Mapping comorbidity in CLL: impact on prognostic factors, treatment patterns and causes of death EC Rotbain, CU Niemann, K Rostgaard, C Da Cunha-Bang, H Hjalgrim, ... Blood 134, 4285, 2019 | 6 | 2019 |
| Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations M Slot, CU Niemann, LH Ehlers, EC Rotbain Blood advances 7 (15), 4186-4196, 2023 | 2 | 2023 |
| Real‐world outcomes upon second‐line treatment in patients with chronic lymphocytic leukaemia N Vainer, K Aarup, MA Andersen, L Wind‐Hansen, T Nielsen, ... British Journal of Haematology 201 (5), 874-886, 2023 | 2 | 2023 |
| Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. I Del Giudice, LV Cappelli, J Delgado, CU Niemann, MA Andersen, ... British Journal of Haematology 201 (2), 2023 | 2 | 2023 |
| Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning M Parviz, R Agius, EC Rotbain, N Vainer, K Aarup, CU Niemann Leukemia & Lymphoma 65 (4), 449-459, 2024 | 1 | 2024 |
| Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia EC Rotbain, C Allmer, K Rostgaard, MA Andersen, N Vainer, ... American journal of hematology 98 (8), 1236-1245, 2023 | 1 | 2023 |
| CLL-IPI applied in Binet A CLL: a nationwide cohort study EC Rotbain, C da Cunha-Bang, C Brieghel, CU Niemann Blood advances 6 (21), 5698-5701, 2022 | 1 | 2022 |
| Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia EC Rotbain, K Rostgaard, MA Andersen, C Da Cunha-Bang, ... Clinical Epidemiology, 1155-1165, 2021 | 1 | 2021 |
| Chronic lymphocytic leukemia comorbidity index (CLL-CI), a novel comorbidity measure, predicts outcomes in the context of targeted agents and in a large National Registry MJ Gordon, A Kaempf, E Rotbain, A Sitlinger, G Shouse, M Mei, ... Blood 138, 2637, 2021 | 1 | 2021 |
| Development of a Nordic frailty index based on hospital contacts and prescribed medications KB Kristensen, PB Jensen, M Bliddal, A Broe, LC Lund, E Rotbain, ... Pharmacoepidemiology and Drug Safety 29 (Suppl. 3), 381, 2020 | 1 | 2020 |
| Basic HTML Version EC Rotbain haematologica 105 (6), 2020 | 1 | 2020 |
| IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis ECC Rotbain, C Da Cunha-Bang, H Hjalgrim, K Rostgaard, MA Andersen, ... Blood 130, 1742, 2017 | 1 | 2017 |
